These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2530770)

  • 21. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New antidepressants and 5-HT uptake inhibitors.
    Montgomery SA
    Acta Psychiatr Scand Suppl; 1989; 350():107-16. PubMed ID: 2530760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
    Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
    J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep and paroxetine: a comparison with mianserin in elderly depressed patients.
    Dorman T
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():53-8. PubMed ID: 1431012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
    Lundmark J; Scheel Thomsen I; Fjord-Larsen T; Manniche PM; Mengel H; Møller-Nielsen EM; Pauser H; Wålinder J
    Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people.
    Phanjoo AL; Wonnacott S; Hodgson A
    Acta Psychiatr Scand; 1991 Jun; 83(6):476-9. PubMed ID: 1909083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
    Romeo R; Patel A; Knapp M; Thomas C
    Int Clin Psychopharmacol; 2004 May; 19(3):125-34. PubMed ID: 15107654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants and the peripheral nervous system.
    Husstedt IW; Kuhs H; Rudolf GA; Brune GG
    Acta Psychiatr Scand Suppl; 1989; 350():147-8. PubMed ID: 2530774
    [No Abstract]   [Full Text] [Related]  

  • 33. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo.
    Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
    Psychopharmacol Bull; 1989; 25(2):272-6. PubMed ID: 2532374
    [No Abstract]   [Full Text] [Related]  

  • 36. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of paroxetine.
    Boyer WF; Feighner JP
    J Clin Psychiatry; 1992 Feb; 53 Suppl():3-6. PubMed ID: 1531819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A placebo-controlled trial of paroxetine in the treatment of major depression.
    Smith WT; Glaudin V
    J Clin Psychiatry; 1992 Feb; 53 Suppl():36-9. PubMed ID: 1531822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First results of an open phase II study with the antidepressant paroxetine.
    Stuppäck C; Schubert H; Barnas C; Mair M; Schifferle I; Unterweger B; Wömhart L; Fleischhacker WW; Hinterhuber H
    Pharmacopsychiatry; 1988 Nov; 21(6):369-70. PubMed ID: 2977442
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mianserin efficacy in the treatment of depression].
    Ostapowicz A; Kośmicki J; Solarz J; Horodnicki JM
    Psychiatr Pol; 1996; 30(1):127-36. PubMed ID: 8722245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.